Fusion between an Algorithm Based on the Characterization of Melanocytic Lesions' Asymmetry with an Ensemble of Convolutional Neural Networks for Melanoma Detection.

Journal: The Journal of investigative dermatology
Published Date:

Abstract

Melanoma is still a major health problem worldwide. Early diagnosis is the first step toward reducing its mortality, but it remains a challenge even for experienced dermatologists. Although computer-aided systems have been developed to help diagnosis, the lack of insight into their predictions is still a significant limitation toward acceptance by the medical community. To tackle this issue, we designed handcrafted expert features representing color asymmetry within the lesions, which are parts of the approach used by dermatologists in their daily practice. These features are given to an artificial neural network classifying between nevi and melanoma. We compare our results with an ensemble of 7 state-of-the-art convolutional neural networks and merge the 2 approaches by computing the average prediction. Our experiments are done on a subset of the International Skin Imaging Collaboration 2019 dataset (6296 nevi, 1361 melanomas). The artificial neural network based on asymmetry achieved an area under the curve of 0.873, sensitivity of 90%, and specificity of 67%; the convolutional neural network approach achieved an area under the curve of 0.938, sensitivity of 91%, and specificity of 82%; and the fusion of both approaches achieved an area under the curve of 0.942, sensitivity of 92%, and specificity of 82%. Merging the knowledge of dermatologists with convolutional neural networks showed high performance for melanoma detection, encouraging collaboration between computer science and medical fields.

Authors

  • Jules Collenne
    Computer Science and Systems Laboratory, CNRS UMR 7020, Aix-Marseille University, Marseille, France. Electronic address: jules.collenne@lis-lab.fr.
  • Jilliana Monnier
    Department of Dermatology and Skin Cancers, CHU la Timone, Aix-Marseille University, Marseille, France.
  • Rabah Iguernaissi
    Computer Science and Systems Laboratory, CNRS UMR 7020, Aix-Marseille University, Marseille, France.
  • Motasem Nawaf
    Computer Science and Systems Laboratory, CNRS UMR 7020, Aix-Marseille University, Marseille, France.
  • Marie-Aleth Richard
    Dermatology and Skin Cancer Department, La Timone Hospital, Assistance Publique Hôpitaux de Marseille, Aix-Marseille University, Marseille, France.
  • Jean-Jacques Grob
    Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix-Marseille University, Marseille, France; Dermatology and Skin Cancer Department, La Timone Hospital, Assistance Publique Hôpitaux de Marseille, Aix-Marseille University, Marseille, France.
  • Caroline Gaudy-Marqueste
    Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix-Marseille University, Marseille, France; Dermatology and Skin Cancer Department, La Timone Hospital, Assistance Publique Hôpitaux de Marseille, Aix-Marseille University, Marseille, France.
  • Séverine Dubuisson
    Computer Science and Systems Laboratory, CNRS UMR 7020, Aix-Marseille University, Marseille, France.
  • Djamal Merad
    Computer Science and Systems Laboratory, CNRS UMR 7020, Aix-Marseille University, Marseille, France.